Three years into the COVID-19 pandemic, with millions of people around the world suffering from long-term complications of the virus, there is still no proven way to treat or prevent Long COVID—besides not getting infected in the first place. Recently, however, there’s been reason for cautious optimism. Researchers have found promising (though preliminary) signs that … Read more
The U.S. maternal mortality rate, already far higher than peer countries, soared during the pandemic. More than 1,200 women in the U.S. died of complications arising from pregnancy or childbirth in 2021, a 40% jump from 2020, according to data released Thursday by the U.S. Centers for Disease Control and Prevention. That amounts to 32.9 … Read more
I became a doctor because I wanted to help people. Like “supporting the community” and “doing what’s right,” the idea of “helping people” can be so vague that it borders on meaningless. And so, having entered medicine with good intentions but without specifics about whom I wanted to help or how I would go about … Read more
Sienna Vaughn, a 16-year-old high school junior in Texas, died after taking a pill she got from a friend that she thought was Percocet. View original article Contributor: Timothy Bella
The FDA is poised to ease access to the overdose antidote, but experts predict limited impact unless the price comes down. View original article Contributor: David Ovalle
It marked the third consecutive year the nation’s maternal mortality rate, long the highest among high-income nations, increased. View original article Contributor: Akilah Johnson
Sienna Vaughn, a 16-year-old high school junior in Texas, died after taking a pill she got from a friend that she thought was Percocet. View original article Contributor: Timothy Bella
The FDA is poised to ease access to the overdose antidote, but experts predict limited impact unless the price comes down. View original article Contributor: David Ovalle
It marked the third consecutive year the nation’s maternal mortality rate, long the highest among high-income nations, increased. View original article Contributor: Akilah Johnson
The company is the third of the three major insulin manufacturers that dominate the U.S. market to announce such a move this month. View original article Contributor: Rebecca Robbins